Sudha Kutty
Executive Vice President, Evidence Products and Services, Canada’s Drug Agency
Sudha Kutty is listed as Executive Vice President, Evidence Products and Services, Canada’s Drug Agency. Sudha spoke at ISPOR Europe 2026 in November 2026 (speaker, “Beyond Pricing: How HTA Informs Health System Decisions Worldwide”). Speaks mainly at Government Administration events.
Compiled from published conference agendas; not yet confirmed by Sudha. Is this you? Claim this profile.
- Sector: Government Administration
About
Sudha Kutty is the Executive Vice-President, Evidence, Products, and Services at Canada's Drug Agency. She is responsible for overseeing a large portfolio of work including pharmaceutical reviews, post market drug evaluation, appropriate use as well as medical devices and clinical interventions. Recognized as a seasoned health care executive, she has more than 25 years of strategic, health care leadership experience. Sudha is passionate about health care and she brings a wealth of experience in promoting health system improvements by actively supporting the adoption of evidence into practice. Sudha holds an Honours BSc in Human Biology and International Relations from the University of Toronto, a degree in law from the University of Western Ontario, and an MBA from the Rotman School of Management at the University of Toronto. She is also a member of the Law Society of Ontario.
Sessions at 1 conference
ISPOR Europe 2026 8 November 2026 – 11 November 2026
- Beyond Pricing: How HTA Informs Health System Decisions Worldwide Speaker · 10 November 2026
Spoke alongside
People who have shared a session with Sudha at events on B2DB.
- Claire Telford Senior Director, Value & Evidence Team Lead, Method’s Innovation · Pfizer Inc. 1 shared session
- Fatimah Alyami Center for Health Technology Assessment, Center for National Health Insurance 1 shared session
- Jessica Daw Sentara Health Plans 1 shared session
- Joseph Mfutso-Bengo Professor · Kamuzu University of Health Sciences 1 shared session
Others from Canada’s Drug Agency
- Zaina Albalawi Member, Formulary Management Expert Committee (FMEC) 2 sessions
- Nicole Mittmann Chief Scientist and Vice-President of Scientific Evidence, Methodologies, and Resources 1 session